RewordedRisk Factors
For those countries outside the U.S. where we have significant sales, a strengthening in the U.S. dollar as we have seen over the past few years or devaluation in the local currency would reduce revenue, operating profit and shareholders' equity due to the impact of foreign exchange translation on our Consolidated Financial Statements.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
We have seen interest rates rise fluctuate significantly in recent years, and while rates fell in 2024, they may rise again in the future due to inflation or other causes.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
These evolving regulations may restrict the use, manufacture, sale and/or distribution of our products or our ability to obtain components of our products, or may require us to report data on our use of certain PFAS. PFAS or PFAS alternatives.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
The pace at which regulators in many jurisdictions are implementing regulatory change is currently heightened across a wide variety of topics including climate change, environmental sustainability, employment and labor, ethics, data privacy, use of artificial intelligence ("AI"), governance, and others.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
•The Company strengthened its balance sheet by reducing total debt by $141 million and net debt by $132 million during the year.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
•Impairment and restructuring charges increased in 2025 compared to 2024 primarily due to severance expense related to the CEO transition, and restructuring charges related to the announced closure of the Company's bearing manufacturing facility in Heilbronn, Germany.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
2025 2024 $ Change Cash provided by (used in): Accounts receivable $ 3.7 $ (14.2) $ 17.9 Unbilled receivables 3.4 3.3 0.1 Inventories (3.1) 9.6 (12.7) Trade accounts payable 18.0 (37.1) 55.1 Other accrued expenses 27.6 (7.1) 34.7 Cash provided by (used in) working capital items $ 49.6 $ (45.5) $ 95.1
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
During 2025, the Company entered into an insurance buy-in contract for its pension obligation related to its defined benefit pension plan in the United Kingdom ("U.K."). Refer to Note 17 - Retirement Benefit Plans in the Notes to the Consolidated Financial Statements for additional information regarding the insurance buy-in contract. The insurance buy-in contract matches cash flows with future benefit payments for participants as of the contract date with the obligation remaining with the plan. The discount rate for this plan has been set at the discount rate inherent in the insurance buy-in contract.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
During the three months ended March 31, 2025, the Company recorded severance of $9.3 million, plus related taxes, for Mr. Mehta's settlement arrangement and release of claims for his termination without cause. Approximately two-thirds of this amount was paid in 2025, with the remaining amounts to be paid in 2026 and 2027. In addition, the Company recorded incremental stock compensation expense related to stock compensation awards issued to Mr. Kyle during the twelve months ended December 31, 2025, as well as other one-time costs associated with the transition in 2025. CEO transition expenses for 2024 relate to the acceleration of certain stock compensation awards for Mr. Kyle and other one-time costs associated with the transition in 2024.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RemovedMD&A
•On September 9, 2024, the Company acquired CGI, Inc. ("CGI"), a Nevada-based manufacturer of precision drive systems serving a broad range of automation markets with a concentration in medical robotics. CGI employs approximately 130 people and has its headquarters and manufacturing facilities in Carson City, Nevada. CGI will further Timken's strategy to expand and scale its leading industrial motion product portfolio.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•Impairment and restructuring charges decreased significantly in 2024 compared to 2023 primarily due to lower impairment charges. During 2023, the Company recorded a pretax goodwill impairment loss for one of its reporting units in the Industrial Motion segment in the amount of $28.3 million.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
The following items highlight the Company's acquisitions and divestitures completed in 2024 and 2023:
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
For measurement purposes, the Company assumed a weighted-average annual rate of increase in the per capita cost (health care cost trend rate) for medical benefits of 7.00% for 2025, declining gradually to 5.0% in 2033 and thereafter for medical and prescription drug benefits. For Medicare Advantage benefits, actual contract rates have been set for 2025 through 2026, and are assumed to increase by $10 per year for 2027 through 2029 and then 6.0% for 2029, declining gradually to 5.0% in 2033 and thereafter. The assumed health care cost trend rate may have a significant effect on the amounts reported. A one percentage point increase in the assumed health care cost trend rate would have increased the 2024 total service and interest cost components by $0.1 million and would have increased the postretirement benefit obligation by $0.7 million. A one percentage point decrease would provide corresponding reductions of $0.1 million and $0.7 million, respectively.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RewordedMD&A
The change in net cash used in/provided by in financing activities in 2025 compared to 2024 compared with 2023 was primarily due to a decrease in net borrowings of $686.2 million and lower proceeds received from the 2024 sale of shares of Timken India Limited ("TIL") as compared to the 2023 sale in the amount 2024 of $52.5 million, partially offset by a decrease $232.3 million that did not repeat in 2025, an increase in the purchase of treasury shares of $210.4 $16.9 million and an increase in noncontrolling dividends paid of $13.9 million, partially offset by an increase in net borrowings of $21.6 million.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
Acquisition intangible amortization 79.1 78.0 65.7 43.9 46.8 47.3 Impairment, restructuring and reorganization 21.8 19.1 60.1 55.1 15.1 29.0 charges (1) Corporate pension and other postretirement 10.8 (1.3) 20.6 2.9 0.3 18.5 benefit related (income) expense (2) Acquisition-related charges (3) — 13.0 31.8 14.8 3.2 3.7 Acquisition-related gain (4) — — — (0.9) (11.1) 2.3 Gain on divestitures and sale of certain assets (5) (4) (2.6) (14.7) (5.2) (2.9) — (0.4) Property losses (recoveries) and related expenses (5) — 1.2 — — — (5.5) expenses (6) Tax indemnification and related items — (1.1) — 0.3 0.2 0.5 CEO succession transition expenses (7) (6) 20.8 3.7 — — — — Noncontrolling interest of above adjustments 4.9 (0.2) (2.1) (5.3) — (0.1) Provision for income taxes (8) (7) (48.7) (41.0) (56.9) (35.9) (35.0) (18.2) Adjusted Net Income $ 374.5 $ 409.4 $ 508.1 $ 480.3 $ 398.8 $ 348.2 Net income attributable to noncontrolling 28.9 22.6 13.9 9.6 12.4 7.9 interest Provision for income taxes (as reported) 98.7 118.9 122.5 133.9 95.1 103.9 Interest expense 110.3 125.1 110.7 74.6 58.8 67.6 Interest income (10.3) (14.9) (9.3) (3.8) (2.3) (3.7) Depreciation and amortization expense (9) (8) 229.0 220.5 200.5 164.0 167.0 164.0 Less:
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The decrease increase in net cash provided by operating activities in 2025 compared to 2024 compared with 2023 was primarily due to the unfavorable favorable impact of working capital items of $43.7 million, a decrease in net income of $32.7 million, a decrease in impairment charges of $29.7 million, partially offset by $95.1 million and the favorable impact of income taxes on cash of $56.5 million due to lower tax payments. $17.2 million, partially offset by a decrease in net income of $58.0 million.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
Net sales decreased increased in 2024 2025 compared to 2023 2024 primarily due to lower organic sales the favorable impact of $276 acquisitions of $38 million (lower demand, favorable pricing) as well as the unfavorable favorable impact of foreign currency exchange of $34 $17 million, partially offset by the lower organic sales of $46 million (lower demand, favorable impact of acquisitions (net of divestitures) of $114 million. pricing).
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The decrease in net cash used in investing activities in 2025 compared to 2024 compared with 2023 was primarily due to a decrease in cash used for acquisitions of $471.4 million, $167.4 million and a decrease in capital expenditures of $17.8 million and an increase $21.8 million, partially offset by a decrease in cash from the net liquidation of short-term marketable securities of $9.5 $19.7 million and a decrease in proceeds from disposals of property, plant and equipment of $13.1 million.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The impact of the net increase reduction in the discount rate used to measure the Company's defined benefit pension obligations was primarily driven by a 95 36 basis point increase decrease in the discount rate used to measure its plan obligations in the United Kingdom ("U.K."), U.K., which increased decreased from 4.48% in 2023 to 5.43% in 2024, 2024 to 5.07% in 2025, and a 43 24 basis point increase decrease in the weighted-average discount rate used to measure its U.S. plan obligations, which increased decreased from 5.40% in 2023 to 5.83% in 2024. 2024 to 5.59% in 2025.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The Company's earnings are expected to be down up in 2025 2026 compared with 2024, to 2025, primarily due to higher pricing, the impact of higher volume, favorable mix, the impact of foreign currency exchange rate changes and lower organic sales volume, material costs, partially offset partially by lower operating incremental tariff costs and the favorable impact of acquisitions. higher SG&A expenses.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The Company expects to generate a higher amount approximately $515 million of cash from operating activities in 2025 2026 compared to 2024, $554.3 million in 2025, driven by improved higher working capital performance, a lower level of capital expenditures, to support increased demand and lower higher cash taxes. taxes, partially offset by higher net income.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The Company expects to generate a higher amount approximately $515 million of cash from operating activities in 2025 2026 compared to 2024, $554.3 million in 2025, driven by improved higher working capital performance, a lower level of capital expenditures, to support increased demand and lower higher cash taxes. taxes, partially offset by higher net income.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
For the year ended December 31, 2024, 2025, the Company recorded a positive non-cash foreign currency translation adjustment of $215.6 million that increased shareholders’ equity, compared to a negative non-cash foreign currency translation adjustment of $156.4 million that decreased shareholders’ equity, compared with a positive non-cash foreign currency translation adjustment of $35.3 million that increased shareholders’ equity for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The effective tax rate for 2024 This was 24.1%, which was unfavorable compared to the U.S. federal statutory rate of 21%, primarily due to partially offset by the unfavorable impact of earnings in foreign jurisdictions where the effective tax rate was higher than 21% and U.S. state and local income taxes. 21%.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
Impairment, restructuring and reorganization charges (1) $ 20.7 $ 17.8 $ 59.3 Corporate pension and other postretirement related expense (income) expense (2) 10.8 (1.3) 20.6 Acquisition-related charges (3) — 13.0 31.8 Property losses and related expenses (4) — 1.2 — Gain on divestitures and sale of certain assets (5) (2.6) (14.7) (2.9) CEO succession transition expenses (6) 20.8 3.7 — Tax indemnification and related items — (1.1) — Total Adjustments 49.7 18.6 108.8 Adjusted EBITDA $ 795.8 $ 844.8 $ 942.0 Net Debt $ 1,557.6 $ 1,689.5 $ 1,977.0 Ratio of Net Debt to Adjusted EBITDA 2.0 2.1 2.0
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new